Stay tuned and follow the latest
developments and news in Molecular Oncology.
We feel joy and pride that “The Smile of the Child” was awarded for its humanitarian work and its contribution to the health sector. Our partnership began in 2022, with […]
Read More
Our recent study ” Microsatellite Instability Is Insufficiently Used as a Biomarker for Lynch Syndrome Testing in Clinical Practice” aimed to determine how often patients with tumors with MSI-high are […]
Read More
Genekor team has joined the event organized by the Romanian Lynch Syndrome Society dedicated to improving the lives of oncology patients. Through this collaboration, we aim to bring real solutions […]
Read More
Genekor supports the efforts of the Hellenic National Anti-Epilepsy Association (E.E.E.E.E.) and the Panhellenic Scientific Association against Epilepsy (P.E.S.E.) for the information and awareness of epilepsy. We believe in equal […]
Read More
Genekor, with a focus on the prevention and early diagnosis of genetic diseases, offers free genetic counseling to all examinees who wish, before, during and/or after genetic testing for hereditary […]
Read More
This year, World Cancer Day coincides with the date of the 8th Annual Conference of the Hellenic Cancer Federation (ELLOK): ‘Man at the Centre: Co-Creating the Context”. In this context, […]
Read More
Approximately 8,000 women with early breast cancer in Greece were able to avoid chemotherapy thanks to Oncotype DX®’s decision guidance This year marks 15 years since the introduction of the […]
Read More
The study by the Genekor Scientific Team, titled “RediScore: Prospective Validation of a Pipeline for Homologous Recombination Deficiency Analysis,” was published in Oncology Letters The study by the Genekor Scientific […]
Read More
prime DXThe prime DX assay provides a detailed blueprint of tumor biology, which is used by the physician to design the most effective individualized treatment plan for the patient.It includes […]
Read More